These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7850417)

  • 1. Endothelin, endothelin receptors, and endothelin antagonists.
    Lüscher TF
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):92-8. PubMed ID: 7850417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-induced vasoconstriction and calcium antagonists.
    Lüscher TF; Yang Z; Kiowski W; Linder L; Dohi Y; Diederich D
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S3-8. PubMed ID: 1289511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin.
    Lüscher TF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S15-22. PubMed ID: 1724999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties.
    Lüscher TF
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 2):S56-60. PubMed ID: 1332560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease.
    Noll G; Wenzel RR; Lüscher TF
    Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):259-67. PubMed ID: 8739256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endothelins on the cardiovascular system.
    Penna C; Rastaldo R; Mancardi D; Cappello S; Pagliaro P; Westerhof N; Losano G
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):645-52. PubMed ID: 16932076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular biology of endothelin.
    Schiffrin EL; Touyz RM
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S2-13. PubMed ID: 9883741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of calcium in the regulation of normal vascular tone and in arterial hypertension].
    Ramón de Berrazueta J
    Rev Esp Cardiol; 1999; 52 Suppl 3():25-33. PubMed ID: 10614146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases].
    Limone P; Boeri E; Molinatti GM
    Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelins and anti-endothelins.
    Bhatt AD
    J Assoc Physicians India; 1997 Nov; 45(11):868-72. PubMed ID: 11229190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor-mediated vasodilatation: effects of organ culture.
    Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
    Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin, vascular hypertrophy, and hypertension.
    Rosendorff C
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):795-802. PubMed ID: 9110124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights on endothelins: a review.
    Ortega Mateo A; de Artiñano AA
    Pharmacol Res; 1997 Nov; 36(5):339-51. PubMed ID: 9441724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The endothelial cell as an endocrine organ--endothelin].
    Forslund T; Metsärinne K
    Tidsskr Nor Laegeforen; 1992 Feb; 112(5):648-52. PubMed ID: 1557733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin, hypertension and vascular disease.
    Vanhoutte PM
    Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.